112194-82-8Relevant academic research and scientific papers
Piperazine compound as PAF-antagonist
-
, (2008/06/13)
Diseases caused by platelet activating factor are prevented and treated by administration to a subject of a therapeutically effective amount of a piperazine compound of the formula: STR1 wherein R1 to R4 are as defined in the specifi
Piperazine compound as PAF-antagonist
-
, (2008/06/13)
The invention relates to a PAF-antagonist pharmaceutical composition comprising a compound of the formula: STR1 wherein R1 is pyridyl(lower)alkyl or thiazolyl(lower)alkyl, R2 is N-lower alkylindolyl(lower)alkyl which may have lower a
